Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
PaperCitations, authors & open-access status
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 856 citations, 2017 year and closed oa status.
856
Citations
2017
Year
closed
OA Status